{"@context":"https://schema.org","@type":"Corporation","name":"BALAXI PHARMA LTD","alternateName":"BALAXI","tickerSymbol":"BALAXI","identifier":"BALAXI","description":"BALAXI PHARMA LTD (BALAXI) financials: Market Cap ₹122Cr., Price ₹22.1, P/E 33.0, ROE 3.95%. Jun 2026: sales ₹15.58 Cr, net profit ₹-1.25 Cr. Quarterly results…","url":"https://fincrux.org/companies/BALAXI","sameAs":["https://fincrux.org/companies/BALAXI"],"dateModified":"2026-10-18T07:16:33.913018","additionalProperty":[{"@type":"PropertyValue","name":"Market Cap","value":"₹122Cr."},{"@type":"PropertyValue","name":"Current Price","value":"₹22.1"},{"@type":"PropertyValue","name":"Stock P/E","value":"33.0"},{"@type":"PropertyValue","name":"ROE","value":"3.95%"},{"@type":"PropertyValue","name":"ROCE","value":"6.07%"},{"@type":"PropertyValue","name":"Book Value","value":"₹24.1"},{"@type":"PropertyValue","name":"Dividend Yield","value":"0.00%"},{"@type":"PropertyValue","name":"52W High / Low","value":"₹43.8/15.2"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://fincrux.org/companies/BALAXI#webpage","name":"BALAXI PHARMA LTD (BALAXI) Financials, Quarterly Results & Ratios","url":"https://fincrux.org/companies/BALAXI","isPartOf":{"@id":"https://fincrux.org/#website"}},"publisher":{"@type":"Organization","name":"Fincrux","url":"https://fincrux.org"},"potentialAction":{"@type":"ViewAction","target":"https://fincrux.org/companies/BALAXI"}}